Skip to main content
Premium Trial:

Request an Annual Quote

BD to Offer Drug Candidate ADME Screening with BioTrove System

NEW YORK (GenomeWeb News) – BioTrove said today that Becton Dickinson will offer BioTrove’s mass spectrometry-based screening and analysis system as part of its ADME analysis services for pharmaceutical and biotech companies
 
Under the agreement, BD will offer BioTrove’s mass spec-based RapidFire Technology as part of its drug absorption, distribution, metabolism, and elimination services offering.
 
The service, which the partners said will allow customers to use the same assay in discovery and development, will initially focus on cytochrome P450 inhibition assays to assess potential drug-drug interactions.
 
Discovering these potential complications early on, BioTrove said, could help researchers save time and money by focusing on the most promising candidates.
 
BioTrove’s VP and GM, Jon Özbal, said in a statement that the service will have a seven-day turnaround.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.